Saturday, October 3, 2026

USD/EUR Is 2% Down In The Last 21 Sessions

USD/EUR Is 2% Down In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 2.51% for the last 21 sessions. At 16:10 EST on Tuesday, 28 March, USD/EUR (USDEUR) is $0.92.

USD/EUR's yearly highs and lows, it's 3.075% up from its 52-week low and 12.068% down from its 52-week high.

News about

  • Usd/jpy bears ignore boj’s kuroda near 130.50 as yields retreat amid upbeat mood. According to FXStreet on Tuesday, 28 March, "On the flip side, the geopolitical fears surrounding China and Russia challenge the market's upbeat sentiment, as well as the USD/JPY bears. ", "It's worth noting that the recently downbeat US data weighed on the hawkish Fed bets, especially after talks of US recession, previously teased by MinneapolisFedPresident Neel Kashkari, which in turn exerted downside pressure on the USD/JPY prices. "
  • Usd/jpy climbs to fresh daily high, around mid-131.00s amid receding safe-haven demand. According to FXStreet on Monday, 27 March, "Apart from this, expectations that the Bank of Japan (BoJ) will tweak its bond yield control policy and whittle down its massive stimulus under new Governor Kazuo Ueda might contribute to capping gains for the USD/JPY pair. ", "A generally positive tone around the equity markets undermines the safe-haven Japanese Yen (JPY), which, in turn, is seen as a key factor acting as a tailwind for the USD/JPY pair. "
  • Usd/jpy price analysis: clings to gains around mid-131.00s, 200-hour SMA holds the key for bulls. According to FXStreet on Monday, 27 March, "Some follow-through buying, however, might prompt a short-covering rally and push the USD/JPY pair towards the 132.80-132.85 region, representing the 38.2% Fibo. ", "The USD/JPY pair could decline further towards the 130.00 psychological mark before eventually dropping back to the multi-week low, around the 129.65 area touched on Friday."
  • Usd/jpy: neutral view amidst global banking turmoil – morgan stanley. According to FXStreet on Monday, 27 March, "Analysts at Morgan Stanley shift their view on the USD/JPY pair to neutral from their previous long recommendation.", "With the risk of the market pricing in further policy convergence, we close our long USD/JPY position and turn neutral until things become much clearer."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com